Skip to main content

Table 7 Correlation between NLR and DFS, 5-year survival and OS by stage, after adjusting it by gender, age, location of the primary tumor, differentiation as well as presence of perineural, vascular, and lymphovascular invasion

From: Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients

  DFS 5-year survival Overall Survival
HR 95% Confidence Interval p value HR 95% Confidence Interval p value HR 95% Confidence Interval p value
Stage I
 NLR > 4.7 1.60 0.19–13.41 0.663 2.06 0.23–18.18 0.514 1.85 0.22–15.88 0.572
Stage II
 NLR > 4.7 2.85 1.21–6.73 0.017 4.06 1.66–9.93 0.002 4.07 1.67–9.91 0.002
Stage III
 NLR > 4.7 1.33 0.54–3.28 0.537 1.28 0.50–3.22 0.605 1.27 0.50–3.18 0.612
\